Bioactivity | (Rac)-SAG is an isoform of SAG (HY-12848). SAG is a potent Smoothened (Smo) receptor agonist (EC50=3 nM; Kd=59 nM). SAG activates the Hedgehog signaling pathway and counteracts Cyclopamine (HY-17024) inhibition of Smo[1][2][3]. |
Target | EC50: 3 nM (Smo) |
Invitro | SAG (0.1 nM-100 μM;30 h) 在 Shh-LIGHT2 细胞中诱导萤火虫荧光素酶表达,EC50 为 3 nM,然后在更高浓度下抑制表达[1]。SAG (1-1000 nM;1 h) 竞争 BODIPY-cyclopamine 与表达 Smo 的 Cos-1 细胞 SAG/Smo 复合物的结合,产生表观解离常数 (Kd) 为 59 nM[1]。SAG (100 nM) 抑制 ShhN 诱导的 Robotnikinin 通路激活的抑制作用[2]。SAG (250 nM;48 h) 显著增加 MDAMB231 细胞中 SMO mRNA 和蛋白的表达[3]。SAG (250 nM;24 和 48 h) 增加 CAXII MDAMB231 细胞在含氧量正常和低氧条件下 24 h 的 mRNA 表达[3]。SAG (250 nM;24 h) 增加 MDAMB231 细胞迁移[3]。 0 --> (Rac)-SAG 相关抗体: |
In Vivo | 在 CD-1 小鼠中,SAG (1.0 mM) 主要在缺损边界诱导更多的成骨,并在八周时间点显著增加 BV/TV[4]。SAG (15-20 mg/kg;ip) 在小鼠中以剂量依赖性方式普遍诱导轴前多指畸形[5]。 |
Name | (Rac)-SAG |
CAS | 364590-63-6 |
Formula | C28H28ClN3OS |
Molar Mass | 490.06 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Guerrini G, et, al. Inhibition of smoothened in breast cancer cells reduces CAXII expression and cell migration. J Cell Physiol. 2018 Dec; 233(12): 9799-9811. [2]. Chen JK, et al. Small molecule modulation of Smoothened activity. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14071-6. [3]. Stanton BZ, et al. A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat Chem Biol. 2009 Mar;5(3):154-6. [4]. Lee S, et al. Combining Smoothened Agonist (SAG) and NEL-like protein-1 (NELL-1) Enhances Bone Healing. Plast Reconstr Surg. 2017 Feb 13 [5]. Fish EW, et al. Preaxial polydactyly following early gestational exposure to the smoothened agonist, SAG, in C57BL/6J mice. Birth Defects Res A Clin Mol Teratol. 2016 Nov 1 |